Mandatum Life Insurance Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,758
Closed -$753K 87
2024
Q1
$753K Hold
4,758
0.25% 43
2023
Q4
$746K Buy
4,758
+1,470
+45% +$225K 0.28% 43
2023
Q3
$512K Buy
+3,288
New +$543K 0.21% 45
2018
Q4
Sell
-28,942
Closed -$4M 142
2018
Q3
$4M Sell
28,942
-3,399
-11% -$452K 0.76% 30
2018
Q2
$3.92M Buy
32,341
+85
+0.3% +$10.6K 0.75% 29
2018
Q1
$4.13M Buy
32,256
+221
+0.7% +$29.9K 0.77% 26
2017
Q4
$4.48M Hold
32,035
0.7% 17
2017
Q3
$4.17M Sell
32,035
-3,201
-9% -$424K 0.56% 18
2017
Q2
$4.66M Sell
35,236
-1,091
-3% -$139K 0.64% 8
2017
Q1
$4.53M Sell
36,327
-605
-2% -$72.3K 0.59% 16
2016
Q4
$4.25M Buy
36,932
+4,059
+12% +$469K 0.58% 13
2016
Q3
$3.88M Buy
32,873
+588
+2% +$71.3K 0.51% 14
2016
Q2
$3.92M Buy
32,285
+1,004
+3% +$114K 0.54% 10
2016
Q1
$3.38M Buy
31,281
+2,184
+8% +$226K 0.46% 14
2015
Q4
$2.99M Buy
+29,097
New +$2.93M 0.41% 21

Other funds holding JNJ

Mandatum Life Insurance Company's JNJ Position: Q2 2024 in Review

Mandatum Life Insurance Company sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 4,758 shares — an estimated $753K sold.

Mandatum Life Insurance Company first reported a position in JNJ in Q4 2015 and held it in 15 quarters. The position peaked at $4.66M in Q2 2017. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Mandatum Life Insurance Company reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 4,758 Johnson & Johnson shares in Q2 2024, an estimated $753K.
  • Mandatum Life Insurance Company first reported a position in Johnson & Johnson in Q4 2015 and held it in 15 quarters.
  • Mandatum Life Insurance Company's Johnson & Johnson position peaked at $4.66M in Q2 2017.
  • 3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Mandatum Life Insurance Company's 13F filing for Q2 2024, filed 1 Aug 2024.